Yichang builds central drug valley Three Gorges pharmaceutical amino acid industry base put into production

On the morning of January 16,, Yichang Three Gorges Pharmaceutical Co., Ltdamino acid industry base in Yichang High-tech Zone Bioindustrial Park officially put into operationOn the same day, Yichang High-tech District and the City Center People's Hospital formally signed an agreement to build a "Yichang Biopharmaceutical Industry Research Center." Yichang Bioindustrial Park will be built into the central medicine valleyg9F
Yichang Three Gorges Pharmaceutical Co., Ltdamino acid industry base project has invested 420 million yuan, the annual production capacity of amino acids will achieve 2200 tonsAfter production, the market share of the product will be increased to 50%, becoming the largest chain amino acid production base in Chinag9F
Yichang Biopharmaceutical Industry Research Center is a public service experimental research and development platform that integrates the functions of biopharmaceutical application and key technology research, outcome incubation and transformation, personnel training and training, science and technology services, etcRelying on the existing medical experimental research platform of the Central People's Hospital, the relevant enterprises of the biopharmaceutical industry are jointly integrated with the application of research and achievements into the focus, and through the development of technology collaborative innovation, we will build a research and development platform for the use of regional lymic resources and key technical research and technology of biomedicine, a new technology industrialization test platform for new products, an integrated and pilot platform for scientific and technological achievements and a technology information service platformg9F
The biopharmaceutical industry is one of the six hundred billion industries that Yichang City has focused on buildingAt present, the high-tech zone has more than 20 biopharmaceutical enterprises, including well-known enterprises such as Renfu Pharmaceuticals, Angie Yeast, Heng'an Pharmaceutical, etc., and has been approved as the first batch of biopharmaceutical high-tech industrialization base in Hubei ProvinceIn 2014, the output value of biopharmaceutical enterprises in the region has exceeded 20 billion yuan, accounting for nearly 10% of the total industrial output valueg9Fg9Fon the morning of January 16, Yichang Three Gorges Pharmaceutical Co., Ltdamino acid industry base in Yichang High-tech Zone Bioindustrial Park officially put into operationOn the same day, Yichang High-tech District and the City Center People's Hospital formally signed an agreement to build a "Yichang Biopharmaceutical Industry Research Center." Yichang Bioindustrial Park will be built into the central medicine valleyg9F
Yichang Three Gorges Pharmaceutical Co., Ltdamino acid industry base project has invested 420 million yuan, the annual production capacity of amino acids will achieve 2200 tonsAfter production, the market share of the product will be increased to 50%, becoming the largest chain amino acid production base in Chinag9F
Yichang Biopharmaceutical Industry Research Center is a public service experimental research and development platform that integrates the functions of biopharmaceutical application and key technology research, outcome incubation and transformation, personnel training and training, science and technology services, etcRelying on the existing medical experimental research platform of the Central People's Hospital, the relevant enterprises of the biopharmaceutical industry are jointly integrated with the application of research and achievements into the focus, and through the development of technology collaborative innovation, we will build a research and development platform for the use of regional lymic resources and key technical research and technology of biomedicine, a new technology industrialization test platform for new products, an integrated and pilot platform for scientific and technological achievements and a technology information service platformg9F
　　The biopharmaceutical industry is one of the six hundred billion industries that Yichang City has focused on building At present, the high-tech zone has more than 20 biopharmaceutical enterprises, including well-known enterprises such as Renfu Pharmaceuticals, Angie Yeast, Heng'an Pharmaceutical, etc., and has been approved as the first batch of biopharmaceutical high-tech industrialization base in Hubei Province In 2014, the output value of biopharmaceutical enterprises in the region has exceeded 20 billion yuan, accounting for nearly 10% of the total industrial output value g9F g9F shared on twitter